WCN26-6668 PIONEER: A BASKET TRIAL OF ATACICEPT IN AUTOIMMUNE-MEDIATED GLOMERULAR DISEASE

Read full text Summarise with VIRAT
Authors: Richard A. Lafayette, Jonathan Barratt, Robert Brenner, James Alan Tumlin, Christoph Wanner, Pamela D. Winterberg, Glenn Matthew Chertow
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Autoimmune glomerular diseases are characterized by the presence of an autoantigen which may be of glomerular or B cell origin; these autoantigens elicit an autoantibody response by B cells. While autoimmune glomerular diseases are associated with a variety of histopathologic profiles, the fundamental pathophysiology of these kidney diseases is conserved. This mechanistic conservation invites consideration of a basket trial approach to investigate the safety and efficacy of a B-cell modulator in a broad range of glomerular diseases.

Fields of Study & Subjects

Renal Diseases and Glomerulopathies Systemic Lupus Erythematosus Research Vasculitis and related conditions

Publication details

Journal / source
Kidney International Reports
Volume
11
Issue
4
Pages
106273–106273
Publication date
25 March 2026
Language
EN